A Clinical Prospective Study to Validate a Risk Scoring Model for the HMGC After Curative Surgery

Clinical trial NCT06023966 · COMPLETED

Trial details

NCT number: NCT06023966
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Predictive Cancer Model Hepatic Metastasis Gastric Cancer

Start date: 2023-09-01
Primary completion: 2025-08-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.